Unique program continues to advance collaborative research worldwide
HUNTSVILLE, Ala., April 7, 2008 /PRNewswire/ -- Open Biosystems, Inc., announced today that leading research institutions, the Institute for Molecular Bioscience and Diamantina Institute at the University of Queensland, and the Biotech Research and Innovation Centre (BRIC) along with the University of Copenhagen have recently purchased access to Open Biosystems shRNAmir technologies for RNAi by joining the Open Access RNAi(TM) Program.
Both institutions purchased access to Open Biosystems' lentiviral shRNAmir human and mouse libraries developed in collaboration with Dr. Greg Hannon and Dr. Steve Elledge and exclusively distributed through Open Biosystems.
"Once complete, the Institute for Molecular Bioscience's lentiviral screening facility will be unique in the Southern Hemisphere," Professor John Hancock, Deputy Director (Research) of the IMB, said. "Open Biosystems' Open Access RNAi Program will give all of our research groups access to this valuable genomic screening resource. This will allow our researchers to conduct whole genome or customized gene set knock down experiments that will greatly facilitate discovery in our cell, developmental biology and cancer research programs."
"The lentiviral shRNAmir libraries are important tools for our high throughput genomic facilities," said Professor Kristian Helin, Director of BRIC. "The research groups at University of Copenhagen will now have access to state-of-the art screening facilities to discover novel genes involved in cell-fate decisions and disease."
"We are excited to see worldwide adoption of our Open Access Program.
This fuels our ongoing mission to make leading edge technology broadly
available in a technically supported and cost-effective way
|SOURCE Open Biosystems, Inc.|
Copyright©2008 PR Newswire.
All rights reserved